This compound is an impurity of trilaciclib, used as a reference standard in pharmaceutical intermediate synthesis. It features a tetracyclic structure with a spiro cyclohexane ring and a chlorine substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1374635-90-1
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate
1-N-Boc-pyrrolidin-2-ylboronic acid
pharmaceutical intermediate
(2R,3S,4S)-2,3,4-Tris(benzyloxy)-4-(4-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one oxalate
pharmaceutical intermediate
Ethyl (2R,3S)-3-(benzoylamino)-2-hydroxybenzenepropanoate
pharmaceutical intermediate
(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol
pharmaceutical intermediate
Tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
pharmaceutical intermediate
TERT-BUTYL (2R,3R)-3-AMINO-2-METHYLPYRROLIDINE-1-CARBOXYLATE
pharmaceutical intermediate
2-Fluoro-4-iodobenzonitrile
pharmaceutical intermediate
4-chlorospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
WTRKUZNZMDTKIX-UHFFFAOYSA-N
C1CCC2(CC1)CNC(=O)C3=CC4=CN=C(N=C4N23)Cl